We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Harbour BioMed announced today it has entered into a multi-year, multifaceted research collaboration agreement with Dana-Farber Cancer Institute to co-develop novel biotherapies in cancer treatment.
Eli Lilly must be seeing value in its broad-ranging research collaboration with the Dana-Farber Cancer Institute, as it’s extending the partnership for another three years.
The Global Foundation for Human Aging Research announces a donation of $75,000 to Dana-Farber Cancer Institute, the cancer treatment and research center designated by the National Cancer Institute in Boston, MA, and affiliate of Harvard Medical School.